Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients

被引：1
|
作者：
Alfredo Campennì
Rosaria Maddalena Ruggeri
Massimiliano Siracusa
Alessio Danilo Comis
Davide Romano
Antonio Vento
Helena Lanzafame
Francesca Capoccetti
Angela Alibrandi
Sergio Baldari
Luca Giovanella
机构：
[1] University of Messina,Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho
[2] University of Messina,Functional Imaging
[3] Nuclear Medicine Unit,Unit of Endocrinology, Department of Clinical and Experimental Medicine
[4] University of Messina,Service Department Macerata Hospital, ASUR Marche AV3
[5] Ente Ospedaliero Cantonale,Unit of Statistical and Mathematical Sciences, Department of Economics
[6] University Hospital and University of Zurich,Clinic for Nuclear Medicine and Competence Centre for Thyroid Diseases, Imaging Institute of Southern Switzerland
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
Stimulated-thyroglobulin; 131-radioiodine therapy; Differentiated thyroid carcinoma; rhTSH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2466 / 2475
页数：9
相关论文
共 50 条
  • [31] Clinical outcome of patients with bone metastases (BM) from differentiated thyroid cancer (DTC)
    Salvatori, M
    Rufini, V
    Romano, L
    Reale, F
    Garganese, MC
    Maussier, ML
    Troncone, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1219 - 1219
  • [32] Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
    Spencer, Carole A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12): : 3615 - 3627
  • [33] Epitope-specific antitumor immunity in differentiated thyroid cancer causes thyroglobulin antibody production in DTC patients
    Bernecker, C.
    Ehlers, M.
    Petho, Z.
    Hautzel, H.
    Charko, R.
    Doetter, U.
    Schinner, S.
    Willenberg, H. S.
    Schott, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [34] No Association of Preablation Thyroglobulin Antibody Positivity and Outcome in Patients with Diffuse Sclerosing Papillary Thyroid Carcinoma
    Yang, L.
    Dong, P.
    Xiao, L.
    Li, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S684 - S685
  • [35] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
    Nascimento, C.
    Borget, I.
    Al Ghuzlan, A.
    Deandreis, D.
    Chami, L.
    Travagli, J. P.
    Hartl, D.
    Lumbroso, J.
    Chougnet, C.
    Lacroix, L.
    Baudin, E.
    Schlumberger, M.
    Leboulleux, S.
    ENDOCRINE-RELATED CANCER, 2011, 18 (02) : R29 - R40
  • [36] Role of thyroglobulin in the management of patients with differentiated thyroid cancer
    Seong Young Kwon
    Yingjie Zhang
    Yansong Lin
    Byeong-Cheol Ahn
    Hee-Seung Bom
    Clinical and Translational Imaging, 2019, 7 : 209 - 217
  • [37] High stimulated thyroglobulin on first follow up in differentiated thyroid cancer patients is really worrisome?
    Gupta, M., Jr.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S599 - S600
  • [38] Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
    Klubo-Gwiezdzinska, Joanna
    Burman, Kenneth D.
    Van Nostrand, Douglas
    Wartofsky, Leonard
    CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 111 - 117
  • [39] Thyroglobulin measurement in the management of patients with differentiated thyroid cancer
    Algeciras-Schimnich, Alicia
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2018, 55 (03) : 205 - 218
  • [40] Role of thyroglobulin in the management of patients with differentiated thyroid cancer
    Kwon, Seong Young
    Zhang, Yingjie
    Lin, Yansong
    Ahn, Byeong-Cheol
    Bom, Hee-Seung
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (03) : 209 - 217
12345